Okine BN et al. |
Lack of effect of chronic pre-treatment with the FAAH inhibitor URB597 on inflammatory pain behaviour: evidence for plastic changes in the endocannabinoid system. |
2012 |
Br. J. Pharmacol. |
pmid:22595021
|
Vandevoorde S and Fowler CJ |
Inhibition of fatty acid amide hydrolase and monoacylglycerol lipase by the anandamide uptake inhibitor VDM11: evidence that VDM11 acts as an FAAH substrate. |
2005 |
Br. J. Pharmacol. |
pmid:15895107
|
Sun Y et al. |
Cannabinoid activation of PPAR alpha; a novel neuroprotective mechanism. |
2007 |
Br. J. Pharmacol. |
pmid:17906680
|
Ryberg E et al. |
The orphan receptor GPR55 is a novel cannabinoid receptor. |
2007 |
Br. J. Pharmacol. |
pmid:17876302
|
Ross RA et al. |
Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens. |
2001 |
Br. J. Pharmacol. |
pmid:11159715
|
Tucker RC et al. |
The endogenous cannabinoid agonist, anandamide stimulates sensory nerves in guinea-pig airways. |
2001 |
Br. J. Pharmacol. |
pmid:11226144
|
Hind WH et al. |
Endocannabinoids modulate human blood-brain barrier permeability in vitro. |
2015 |
Br. J. Pharmacol. |
pmid:25651941
|
Woodhams SG et al. |
Spinal administration of the monoacylglycerol lipase inhibitor JZL184 produces robust inhibitory effects on nociceptive processing and the development of central sensitization in the rat. |
2012 |
Br. J. Pharmacol. |
pmid:22924700
|
Ghasemi M et al. |
Role of the nitric oxide pathway and the endocannabinoid system in neurogenic relaxation of corpus cavernosum from biliary cirrhotic rats. |
2007 |
Br. J. Pharmacol. |
pmid:17486141
|
Thors L and Fowler CJ |
Is there a temperature-dependent uptake of anandamide into cells? |
2006 |
Br. J. Pharmacol. |
pmid:16865094
|
Van den Bossche I and Vanheel B |
Influence of cannabinoids on the delayed rectifier in freshly dissociated smooth muscle cells of the rat aorta. |
2000 |
Br. J. Pharmacol. |
pmid:10960073
|
Lau BK et al. |
Endocannabinoid modulation by FAAH and monoacylglycerol lipase within the analgesic circuitry of the periaqueductal grey. |
2014 |
Br. J. Pharmacol. |
pmid:25041240
|
Hillard CJ and Jarrahian A |
Cellular accumulation of anandamide: consensus and controversy. |
2003 |
Br. J. Pharmacol. |
pmid:12970089
|
O'Sullivan SE et al. |
Heterogeneity in the mechanisms of vasorelaxation to anandamide in resistance and conduit rat mesenteric arteries. |
2004 |
Br. J. Pharmacol. |
pmid:15148250
|
Randall MD et al. |
The complexities of the cardiovascular actions of cannabinoids. |
2004 |
Br. J. Pharmacol. |
pmid:15131000
|
Gardener MJ et al. |
Functional evidence of a role for two-pore domain potassium channels in rat mesenteric and pulmonary arteries. |
2004 |
Br. J. Pharmacol. |
pmid:15066906
|
Romano MR and Lograno MD |
Cannabinoid agonists induce relaxation in the bovine ophthalmic artery: evidences for CB1 receptors, nitric oxide and potassium channels. |
2006 |
Br. J. Pharmacol. |
pmid:16474412
|
Chicca A et al. |
The antinociceptive triterpene β-amyrin inhibits 2-arachidonoylglycerol (2-AG) hydrolysis without directly targeting cannabinoid receptors. |
2012 |
Br. J. Pharmacol. |
pmid:22646533
|
Brighton PJ et al. |
Characterization of the endocannabinoid system, CB(1) receptor signalling and desensitization in human myometrium. |
2011 |
Br. J. Pharmacol. |
pmid:21486283
|
Di Marzo V et al. |
The role of endocannabinoids in the regulation of gastric emptying: alterations in mice fed a high-fat diet. |
2008 |
Br. J. Pharmacol. |
pmid:18223666
|
De Petrocellis L et al. |
A re-evaluation of 9-HODE activity at TRPV1 channels in comparison with anandamide: enantioselectivity and effects at other TRP channels and in sensory neurons. |
2012 |
Br. J. Pharmacol. |
pmid:22861649
|
Ho WS and Randall MD |
Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol. |
2007 |
Br. J. Pharmacol. |
pmid:17245358
|
Wheal AJ et al. |
Effects of chronic nitric oxide synthase inhibition on the cardiovascular responses to cannabinoids in vivo and in vitro. |
2007 |
Br. J. Pharmacol. |
pmid:17245361
|
Makwana R et al. |
Pharmacological characterization of cannabinoid receptor activity in the rat-isolated ileum myenteric plexus-longitudinal muscle preparation. |
2010 |
Br. J. Pharmacol. |
pmid:20233228
|
Gamaleddin I et al. |
The selective anandamide transport inhibitor VDM11 attenuates reinstatement of nicotine seeking behaviour, but does not affect nicotine intake. |
2011 |
Br. J. Pharmacol. |
pmid:21501143
|
Howlett AC et al. |
Endocannabinoid tone versus constitutive activity of cannabinoid receptors. |
2011 |
Br. J. Pharmacol. |
pmid:21545414
|
Thors L et al. |
Biochanin A, a naturally occurring inhibitor of fatty acid amide hydrolase. |
2010 |
Br. J. Pharmacol. |
pmid:20590565
|
Booker L et al. |
The fatty acid amide hydrolase (FAAH) inhibitor PF-3845 acts in the nervous system to reverse LPS-induced tactile allodynia in mice. |
2012 |
Br. J. Pharmacol. |
pmid:21506952
|
Mukhopadhyay P et al. |
CB1 cannabinoid receptors promote oxidative/nitrosative stress, inflammation and cell death in a murine nephropathy model. |
2010 |
Br. J. Pharmacol. |
pmid:20590569
|
Rajesh M et al. |
Cannabinoid-1 receptor activation induces reactive oxygen species-dependent and -independent mitogen-activated protein kinase activation and cell death in human coronary artery endothelial cells. |
2010 |
Br. J. Pharmacol. |
pmid:20590572
|
Jamshidi N and Taylor DA |
Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats. |
2001 |
Br. J. Pharmacol. |
pmid:11704633
|
McHugh D et al. |
Δ(9) -Tetrahydrocannabinol and N-arachidonyl glycine are full agonists at GPR18 receptors and induce migration in human endometrial HEC-1B cells. |
2012 |
Br. J. Pharmacol. |
pmid:21595653
|
Randall MD |
The cardiovascular actions of anandamide: more targets? |
2005 |
Br. J. Pharmacol. |
pmid:15834438
|
Kwolek G et al. |
Central and peripheral components of the pressor effect of anandamide in urethane-anaesthetized rats. |
2005 |
Br. J. Pharmacol. |
pmid:15834445
|
Li Q et al. |
Electrophysiological effects of anandamide on rat myocardium. |
2009 |
Br. J. Pharmacol. |
pmid:20050190
|
Craib SJ et al. |
A possible role of lipoxygenase in the activation of vanilloid receptors by anandamide in the guinea-pig bronchus. |
2001 |
Br. J. Pharmacol. |
pmid:11522594
|
Underdown NJ et al. |
Anandamide reduces infarct size in rat isolated hearts subjected to ischaemia-reperfusion by a novel cannabinoid mechanism. |
2005 |
Br. J. Pharmacol. |
pmid:16158067
|
Scherma M et al. |
The anandamide transport inhibitor AM404 reduces the rewarding effects of nicotine and nicotine-induced dopamine elevations in the nucleus accumbens shell in rats. |
2012 |
Br. J. Pharmacol. |
pmid:21557729
|
Lever IJ and Malcangio M |
CB(1) receptor antagonist SR141716A increases capsaicin-evoked release of Substance P from the adult mouse spinal cord. |
2002 |
Br. J. Pharmacol. |
pmid:11786475
|
Ishac EJ et al. |
Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves. |
1996 |
Br. J. Pharmacol. |
pmid:8864538
|
Moezi L et al. |
Anandamide mediates hyperdynamic circulation in cirrhotic rats via CB(1) and VR(1) receptors. |
2006 |
Br. J. Pharmacol. |
pmid:17043671
|
Steffens M et al. |
Cannabinoid CB1 receptor-mediated modulation of evoked dopamine release and of adenylyl cyclase activity in the human neocortex. |
2004 |
Br. J. Pharmacol. |
pmid:14993102
|
Izzo AA et al. |
Peripheral endocannabinoid dysregulation in obesity: relation to intestinal motility and energy processing induced by food deprivation and re-feeding. |
2009 |
Br. J. Pharmacol. |
pmid:19371345
|
Maione S et al. |
Antinociceptive effects of tetrazole inhibitors of endocannabinoid inactivation: cannabinoid and non-cannabinoid receptor-mediated mechanisms. |
2008 |
Br. J. Pharmacol. |
pmid:18660824
|
Ho WS et al. |
'Entourage' effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors. |
2008 |
Br. J. Pharmacol. |
pmid:18695637
|
Ghafouri N et al. |
Inhibition of monoacylglycerol lipase and fatty acid amide hydrolase by analogues of 2-arachidonoylglycerol. |
2004 |
Br. J. Pharmacol. |
pmid:15492019
|
Kagaya M et al. |
Characterization of the anandamide induced depolarization of guinea-pig isolated vagus nerve. |
2002 |
Br. J. Pharmacol. |
pmid:12183329
|
Gardiner SM et al. |
Complex regional haemodynamic effects of anandamide in conscious rats. |
2002 |
Br. J. Pharmacol. |
pmid:11959791
|
Jia Y et al. |
Anandamide induces cough in conscious guinea-pigs through VR1 receptors. |
2002 |
Br. J. Pharmacol. |
pmid:12411414
|
Geraghty DP and Mazzone SB |
Respiratory actions of vanilloid receptor agonists in the nucleus of the solitary tract: comparison of resiniferatoxin with non-pungent agents and anandamide. |
2002 |
Br. J. Pharmacol. |
pmid:12411424
|